CHARLES RIVER LABORATORIES
CRLNYSE🏆 #615 by market capEarnings Feb 16 · PostUS Equity
$314.32▼ $13.61 (−4.15%)
Market closed · at closeTrack CRL
Get earnings, price moves & breaking news on Telegram
24h▼ 4.2%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$15.01B
Mid Cap
📈Revenue Growth (YoY)
-1.2%
Declining
📊Gross Margin
35.1%
Healthy
💵FCF Margin
10.4%
Healthy
⚖️P/S Ratio
3.8x
Fair
Otter Score
68
Fair
CHARLES RIVER LABORATORIES
CRLAnalyst Ratings
Price
$314.32
Total
37
Raised
5
Lowered
5
Avg PT
$313.67
H / L
$388 / $219
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-11-05 | $322.00 | +2.40% |
UBS | Reiterated | Buy | 2026-11-05 | $357.00 | +13.60% |
Evercore ISI Group | Reiterated | Outperform | 2026-11-05 | — | — |
Barclays | Reiterated | Overweight | 2026-11-05 | $330.00 | +5.00% |
Morgan Stanley | Reiterated | Overweight | 2026-10-13 | $340.00 | +8.20% |
Jefferies | Reiterated | Buy | 2026-09-28 | $340.00 | +8.20% |
Mizuho | Reiterated | Neutral | 2026-09-25 | — | — |
TD Cowen | Reiterated | Buy | 2026-09-25 | $388.00 | +23.40% |
Deutsche Bank | Reiterated | Buy | 2026-09-25 | $320.00 | +1.80% |
Baird | Reiterated | Outperform | 2026-09-25 | — | — |
JP Morgan | Upgraded | Neutral → Overweight | 2026-08-06 | $390.00 | +24.10% |
CLSA | Downgraded | Outperform → Hold | 2026-07-20 | $219.00 | −30.30% |
Citigroup | Reiterated | Buy | 2026-01-16 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2025-10-06 | — | — |
Redburn Atlantic | Upgraded | Neutral → Buy | 2025-05-23 | — | — |
Goldman Sachs | Downgraded | Buy → Neutral | 2025-03-21 | $290.00 | −7.70% |
B of A Securities | Reiterated | Neutral | 2024-12-13 | — | — |
Argus Research | Downgraded | Buy → Hold | 2024-06-28 | $330.00 | +5.00% |
Guggenheim | Downgraded | Buy → Neutral | 2024-02-15 | $369.00 | +17.40% |
Wells Fargo | Reiterated | Overweight | 2023-09-22 | $325.00 | +3.40% |
Credit Suisse | Reiterated | Outperform | 2023-05-12 | $385.00 | +22.50% |
Keybanc | Reiterated | Overweight | 2022-05-05 | $300.00 | −4.60% |
Stephens & Co. | Reiterated | Overweight | 2022-04-07 | — | — |
Truist Securities | Reiterated | Buy | 2021-05-25 | — | — |
KeyBanc | Reiterated | Overweight | 2020-11-24 | $300.00 | −4.60% |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-05-08 | — | — |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2020-02-18 | — | — |
CFRA | Reiterated | Strong Buy | 2020-02-11 | — | — |
Bank of America | Downgraded | Buy → Neutral | 2019-10-18 | — | — |
Raymond James | Reiterated | Outperform | 2018-11-08 | — | — |
Argus | Reiterated | Buy | 2018-08-27 | — | — |
Mitsubishi UFJ | Reiterated | Neutral | 2018-04-20 | — | — |
Gabelli & Co. | Reiterated | Buy | 2016-04-26 | — | — |
Edward Jones | Upgraded | Neutral → Buy | 2015-05-04 | — | — |
Cantor Fitzgerald | Reiterated | Buy | 2013-10-01 | — | — |
Sterne Agee | Reiterated | Buy | 2013-06-11 | — | — |
ISI Group | Reiterated | Neutral | 2013-02-20 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-11-05
$322.00
+2.40%
UBS
Reiterated · Buy · 2026-11-05
$357.00
+13.60%
Evercore ISI Group
Reiterated · Outperform · 2026-11-05
—
—
Barclays
Reiterated · Overweight · 2026-11-05
$330.00
+5.00%
Morgan Stanley
Reiterated · Overweight · 2026-10-13
$340.00
+8.20%
Jefferies
Reiterated · Buy · 2026-09-28
$340.00
+8.20%
Mizuho
Reiterated · Neutral · 2026-09-25
—
—
TD Cowen
Reiterated · Buy · 2026-09-25
$388.00
+23.40%
Deutsche Bank
Reiterated · Buy · 2026-09-25
$320.00
+1.80%
Baird
Reiterated · Outperform · 2026-09-25
—
—
JP Morgan
Upgraded · Neutral → Overweight · 2026-08-06
$390.00
+24.10%
CLSA
Downgraded · Outperform → Hold · 2026-07-20
$219.00
−30.30%
Citigroup
Reiterated · Buy · 2026-01-16
—
—
William Blair
Upgraded · Market Perform → Outperform · 2025-10-06
—
—
Redburn Atlantic
Upgraded · Neutral → Buy · 2025-05-23
—
—
Goldman Sachs
Downgraded · Buy → Neutral · 2025-03-21
$290.00
−7.70%
B of A Securities
Reiterated · Neutral · 2024-12-13
—
—
Argus Research
Downgraded · Buy → Hold · 2024-06-28
$330.00
+5.00%
Guggenheim
Downgraded · Buy → Neutral · 2024-02-15
$369.00
+17.40%
Wells Fargo
Reiterated · Overweight · 2023-09-22
$325.00
+3.40%
Credit Suisse
Reiterated · Outperform · 2023-05-12
$385.00
+22.50%
Keybanc
Reiterated · Overweight · 2022-05-05
$300.00
−4.60%
Stephens & Co.
Reiterated · Overweight · 2022-04-07
—
—
Truist Securities
Reiterated · Buy · 2021-05-25
—
—
KeyBanc
Reiterated · Overweight · 2020-11-24
$300.00
−4.60%
SunTrust Robinson Humphrey
Reiterated · Buy · 2020-05-08
—
—
Wolfe Research
Upgraded · Peer Perform → Outperform · 2020-02-18
—
—
CFRA
Reiterated · Strong Buy · 2020-02-11
—
—
Bank of America
Downgraded · Buy → Neutral · 2019-10-18
—
—
Raymond James
Reiterated · Outperform · 2018-11-08
—
—
Argus
Reiterated · Buy · 2018-08-27
—
—
Mitsubishi UFJ
Reiterated · Neutral · 2018-04-20
—
—
Gabelli & Co.
Reiterated · Buy · 2016-04-26
—
—
Edward Jones
Upgraded · Neutral → Buy · 2015-05-04
—
—
Cantor Fitzgerald
Reiterated · Buy · 2013-10-01
—
—
Sterne Agee
Reiterated · Buy · 2013-06-11
—
—
ISI Group
Reiterated · Neutral · 2013-02-20
—
—
One row per institution · price target from the firm's latest published target